08-08-2013, 03:45 PM
Jul 31, 2013
AstraZeneca Plc said second-quarter profit fell 12 percent as generic competition to some of its best-selling medicines eroded sales by $500 million. Its best-selling drugs face generic competition in the core areas of respiratory, inflammation and autoimmune diseases, (Bloomberg)
--------------------------------------
July 23, 2013
AstraZeneca said Tuesday that police in Shanghai questioned two managers who worked with a sales representative detained last Friday. AstraZeneca says it has no reason to believe that the questioning of its staff by Chinese police is linked to bribery claims against GlaxoSmithKline. (CNN)
AstraZeneca Plc said second-quarter profit fell 12 percent as generic competition to some of its best-selling medicines eroded sales by $500 million. Its best-selling drugs face generic competition in the core areas of respiratory, inflammation and autoimmune diseases, (Bloomberg)
--------------------------------------
July 23, 2013
AstraZeneca said Tuesday that police in Shanghai questioned two managers who worked with a sales representative detained last Friday. AstraZeneca says it has no reason to believe that the questioning of its staff by Chinese police is linked to bribery claims against GlaxoSmithKline. (CNN)
![[+]](https://www.biotechnologyforums.com/images/netpen-pro/collapse_collapsed.png)